Addex Therapeutics Ltd (ADXN) Q4 2024 Earnings Call Highlights: Strategic Spinout and Financial ...

By Yahoo! Finance | 1 month ago

Mikhail Kalinichev discussed dipraglurant's potential in neuro rehabilitation, focusing on its tolerability and upcoming clinical studies.

Did you find this insightful?